CMS considers easing PET reimbursement for most cancers

03/15/2013 | AuntMinnie.com (free registration)

CMS has released a decision memo with a proposal to lift the requirement that FDG-PET scans in cases involving solid tumors be reported to the National Oncologic PET Registry. Providers will no longer have to send the data to the registry as a reimbursement condition if the proposal is approved. CMS said it will reimburse one FDG-PET or PET/CT scan used to assess initial cancer therapy for most indications except prostate cancer. Coverage for subsequent scans will be determined by local Medicare contractors, CMS said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC